InvestLog
RARE Ultragenyx Pharmaceutical Inc. logo

RARE Ultragenyx Pharmaceutical Inc.

Healthcare
$23.14-1.07%ClosedMarket Cap: $2.28B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

30

Dispositions

4

Buy/Sell Ratio

7.50

Net Shares

+927,306

Shares Acquired

942,756

Shares Disposed

15,450

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon May 18SULIMAN SHEHNAAZdirectorSell5,740$25.1227,951
Mon May 18SULIMAN SHEHNAAZdirectorSell14,058$25.8014,058
Mon May 18SULIMAN SHEHNAAZdirectorSell7,751$0.0033,691
Mon May 18Sanders Corazon (Corsee) D.directorSell14,058$25.8014,058
Mon May 18Sanders Corazon (Corsee) D.directorSell7,751$0.0023,095
Mon May 18Ray AmritdirectorSell14,058$25.8014,058
Mon May 18Ray AmritdirectorSell7,751$0.0031,116
Mon May 18NARACHI MICHAELdirectorSell7,751$0.0040,441
Mon May 18Fust Matthew KdirectorSell14,058$25.8014,058
Mon May 18Fust Matthew KdirectorSell7,751$0.0033,696
Wed May 06Crombez Ericofficer: EVP and Chief Medical OfficerSell344$24.96111,189
Mon May 04Horn Howardofficer: Chief Financial OfficerSell4,683$24.90110,342
Fri Apr 24Huizenga Theodore Alanofficer: SVP, Chief Accounting OfficerSell20,241$0.0068,911
Fri Apr 24Huizenga Theodore Alanofficer: SVP, Chief Accounting OfficerSell7,348$24.617,348
Mon Apr 20Pinion John Richardofficer: See RemarksSell79,936$24.5279,936